Tg Therapeutics (TGTX) Stock Price, Quote & News

Company Profile

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. It provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. The company's de...

Industry: Biotechnology

Sector: Healthcare

Phone: 212 554 4484

Fax: 212 554 4531

Website: www.tgtherapeutics.com

Address:

3020 Carrington Mill Blvd., Suite 475, Morrisville, United States

TroyTiger Feb. 3 at 11:55 PM

$TGTX back over 30 tomorrow ;)

0 · Reply

Sciguy67 Feb. 3 at 11:52 PM

$TGTX NVO issues are very different from TGTX.

1 · Reply

TheGunnerAB Feb. 3 at 11:23 PM

$TGTX no words....

0 · Reply

Chartist0_0 Feb. 3 at 11:09 PM

$TGTX Did you ever wonder what would ultimately happen to your stock? Well, take a look at NVO for a blue print.

0 · Reply

Ttubular Feb. 3 at 10:29 PM

$TGTX how did we finish green?

1 · Reply

neilinva Feb. 3 at 10:06 PM

$TGTX I would say we are at PEAK Pessimism! Still Bullish - GLTA!

0 · Reply

Luckybreak Feb. 3 at 9:46 PM

$TGTX Last July the family pets were all ok with $80 Now destiny the bull/blue the husky wants $100 plus

0 · Reply

Luckybreak Feb. 3 at 9:38 PM

$TGTX Mike is going to take us to the promised land . We are in a unique situation.MW hold almost 1/2 billion $$ worth of stock. Most bio pharmaceutical companies CEO hold less than 1% in stocks .

0 · Reply

ramdawg Feb. 3 at 9:30 PM

$GME $TGTX Why is it your biggest investment if you are so negative? Why wouldn't you just sell and move on?

2 · Reply

WolfOfBaySt2025 Feb. 3 at 9:23 PM

$TGTX I will no longer debate with people who are within an echo chamber . blocked and the keys gone . I own TGTX , its my largest single investment within my twenty year investing career . I am extremley concerned about Mikes compensation. The same people who are saying hold for subq or q4 2026 are the same ones who in 2025 were saying we would be at 50 in January 2026. You’re making excuses for someone whos making ten million a year plus shares, its extremely concerning from a mental health standpoint . This is not $GME it doesn‘t need excuses it needs leadership .

3 · Reply

These under-the-radar stocks combine fast growth with big upside potential

AGYS ASTH BBT CORT CTRE DCOM DOCN

Jan 15, 2026, 10:24 AM EST - 19 days ago

TG Therapeutics: The "Exit Velocity" You Can't Ignore (Rating Upgrade)

Jan 13, 2026, 6:46 PM EST - 21 days ago

TG Therapeutics, Inc. (TGTX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 13, 2026, 5:05 PM EST - 21 days ago

TG Therapeutics Stock Climbs After The Bell: Here's Why

Jan 7, 2026, 7:30 AM EST - 27 days ago

TG Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Dec 30, 2025, 11:00 AM EST - 5 weeks ago

TG Therapeutics: What Wall Street Isn't Telling You

Nov 28, 2025, 7:30 AM EST - 2 months ago

TG Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference

Nov 18, 2025, 5:23 PM EST - 2 months ago

TG Therapeutics: Concerns About Slowing Growth And New Competition

Nov 17, 2025, 5:49 PM EST - 2 months ago

TG Therapeutics: Positives From Q3'25 Earnings, But Competitors Progressing

Nov 3, 2025, 3:48 PM EST - 3 months ago

TG Therapeutics Q3 Earnings: Strong Quarter For Briumvi As CD20 Market Grows

Nov 3, 2025, 11:56 AM EST - 3 months ago

TG Therapeutics, Inc. (TGTX) Q3 2025 Earnings Call Transcript

Oct 31, 2025, 7:30 AM EDT - 3 months ago

TG Therapeutics to Host Conference Call on Third Quarter 2025 Financial Results and Business Update

Oct 28, 2025, 7:30 AM EDT - 3 months ago

TG Therapeutics Completes Enrollment in the Phase 3 ENHANCE Trial Evaluating its New Simplified Dosing Schedule for BRIUMVI

Sep 24, 2025, 9:10 AM EDT - 4 months ago

New Data for BRIUMVI® Demonstrate 89.9% of Patients with Relapsing Multiple Sclerosis Were Free from Disability Progression After 6 Years of Continuous BRIUMVI Treatment

Sep 10, 2025, 7:30 AM EDT - 5 months ago

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at the 2025 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting

Sep 8, 2025, 7:30 AM EDT - 5 months ago

TG Announces Phase 3 Trial for Subcutaneous BRIUMVI Commenced Enrollment

Sep 4, 2025, 7:57 AM EDT - 5 months ago

TG Therapeutics, Inc. (TGTX) Presents at Cantor Global Healthcare Conference 2025 Transcript

Sep 4, 2025, 7:30 AM EDT - 5 months ago

TG Therapeutics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Sep 3, 2025, 7:30 AM EDT - 5 months ago

TG Therapeutics Announces Completion of Existing Share Repurchase Program and Authorization of New $100 Million Program

Aug 28, 2025, 8:00 AM EDT - 5 months ago

TG Therapeutics to Participate in the Cantor Global Healthcare Conference

Aug 4, 2025, 10:19 AM EDT - 6 months ago

TG Therapeutics, Inc. (TGTX) Q2 2025 Earnings Call Transcript

Aug 4, 2025, 7:00 AM EDT - 6 months ago

TG Therapeutics Reports Second Quarter 2025 Financial Results and Raises BRIUMVI Revenue Guidance

Jul 30, 2025, 7:30 AM EDT - 6 months ago

TG Therapeutics to Host Conference Call on Second Quarter 2025 Financial Results and Business Update

Jun 25, 2025, 4:05 PM EDT - 7 months ago

TG Therapeutics: Another Possible Avenue Of MS Growth With Azer-Cel

Jun 9, 2025, 4:51 PM EDT - 8 months ago

Evercore ISI's Julian Emanuel says now is the time to buy small-caps

CNS LEU RMBS SFM

Jun 6, 2025, 7:30 AM EDT - 8 months ago

TG Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

May 28, 2025, 6:00 AM EDT - 8 months ago

TG Therapeutics: Estimates Could Soon Be Raised Again

May 27, 2025, 7:30 AM EDT - 9 months ago

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting

May 5, 2025, 4:37 PM EDT - 9 months ago

TG Therapeutics Falls Short On Earnings, But Briumvi Sales Steal the Show

May 5, 2025, 1:30 PM EDT - 9 months ago

TG Therapeutics: Share Price Slip On Q1 Earnings Unsurprising Given Challenges

May 5, 2025, 10:55 AM EDT - 9 months ago

TG Therapeutics, Inc. (TGTX) Q1 2025 Earnings Call Transcript

May 5, 2025, 7:00 AM EDT - 9 months ago

TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance

Apr 30, 2025, 7:30 AM EDT - 9 months ago

TG Therapeutics to Host Conference Call on First Quarter 2025 Financial Results and Business Update

Apr 10, 2025, 7:30 AM EDT - 10 months ago

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

Apr 7, 2025, 7:30 AM EDT - 10 months ago

TG Therapeutics Announces Two Publications Highlighting BRIUMVI in Medical Journals

Mar 21, 2025, 11:50 AM EDT - 11 months ago

Stock Of The Day: TG Therapeutics Breaks Out, May Head Higher

Mar 15, 2025, 8:42 AM EDT - 11 months ago

Precision & TG Therapeutics: Unlocking Value With ARCUS, BRIUMVI And Azer-Cel

Mar 14, 2025, 2:04 PM EDT - 11 months ago

TG Therapeutics: Bright Outlook, Bolstered By Briumvi And Upcoming Trials

Mar 12, 2025, 4:11 PM EDT - 11 months ago

TG Therapeutics: Exciting Briumvi Performance, Looking To Re-Enter

Mar 7, 2025, 7:30 AM EST - 11 months ago

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

Mar 4, 2025, 7:03 AM EST - 1 year ago

Privia Health, Corcept and three other low-key but high-earnings growth potential stocks to invest in 2025

CORT GILD PRVA TKO

Mar 3, 2025, 3:59 PM EST - 1 year ago

TG Therapeutics: A Wonderful Hold

Mar 3, 2025, 11:55 AM EST - 1 year ago

TG Therapeutics, Inc. (TGTX) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 7:30 AM EST - 1 year ago

TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum

Feb 26, 2025, 7:30 AM EST - 1 year ago

TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2024 Financial Results and Business Update

Feb 18, 2025, 10:20 AM EST - 1 year ago

20 stocks of companies expected to put up numbers to back investors' new ‘growth mindset'

ARWR AUB CRK CYTK EXE KRYS MARA

Jan 23, 2025, 2:48 PM EST - 1 year ago

TG Therapeutics: Entering 2025 With Increased Investor Expectations

Jan 21, 2025, 2:17 AM EST - 1 year ago

TG Therapeutics: 2025 Revenues Will Smash Expectations

Jan 13, 2025, 11:38 PM EST - 1 year ago

TG Therapeutics: Subcutaneous Briumvi Data A Key Near-Term Catalyst

Jan 9, 2025, 7:30 AM EST - 1 year ago

TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

TroyTiger Feb. 3 at 11:55 PM

$TGTX back over 30 tomorrow ;)

0 · Reply

Sciguy67 Feb. 3 at 11:52 PM

$TGTX NVO issues are very different from TGTX.

1 · Reply

TheGunnerAB Feb. 3 at 11:23 PM

$TGTX no words....

0 · Reply

Chartist0_0 Feb. 3 at 11:09 PM

$TGTX Did you ever wonder what would ultimately happen to your stock? Well, take a look at NVO for a blue print.

0 · Reply

Ttubular Feb. 3 at 10:29 PM

$TGTX how did we finish green?

1 · Reply

neilinva Feb. 3 at 10:06 PM

$TGTX I would say we are at PEAK Pessimism! Still Bullish - GLTA!

0 · Reply

Luckybreak Feb. 3 at 9:46 PM

$TGTX Last July the family pets were all ok with $80 Now destiny the bull/blue the husky wants $100 plus

0 · Reply

Luckybreak Feb. 3 at 9:38 PM

$TGTX Mike is going to take us to the promised land . We are in a unique situation.MW hold almost 1/2 billion $$ worth of stock. Most bio pharmaceutical companies CEO hold less than 1% in stocks .

0 · Reply

ramdawg Feb. 3 at 9:30 PM

$GME $TGTX Why is it your biggest investment if you are so negative? Why wouldn't you just sell and move on?

2 · Reply

WolfOfBaySt2025 Feb. 3 at 9:23 PM

3 · Reply

PotionX1900 Feb. 3 at 9:21 PM

$TGTX that was an odd chart today.

0 · Reply

BioHedge Feb. 3 at 9:12 PM

$TGTX WolfOfTrailerPark2025 is his real name.

0 · Reply

WolfOfBaySt2025 Feb. 3 at 9:10 PM

$TGTX Full blown austism at its finest . Yes , everyone who is critical of a management team or CEO making ten million dollars is a ”fake basher” who is being negative before a ”big move” are you MAGA too mouth breather ? Just smile and nod as your investment thesis gets blown up daily .

1 · Reply

BioHedge Feb. 3 at 8:01 PM

$TGTX The week is early... but you can look forward to our "Negative Nancy" Awards this Friday. Also, I'll be introducing a new category, "Soft Basher" of the Week! Will it be you?

0 · Reply

ern1in Feb. 3 at 7:58 PM

$TGTX / BRIUMVI / SUB-Q 🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥

0 · Reply

WolfOfBaySt2025 Feb. 3 at 7:14 PM

$TGTX Cope. This board does not own enough shares for a hedge fund to waste their time and energy on . It couldn’t just be poor stock performance right? right !?

1 · Reply

grk2025 Feb. 3 at 7:08 PM

$TGTX may be they want ST board to turn completely bearish before a big move

1 · Reply

grk2025 Feb. 3 at 6:56 PM

$TGTX 🚀 take off

1 · Reply

CloudMatt Feb. 3 at 6:26 PM

$TGTX is really the worst stock, the worst drug, the worst CEO, the worst clients, the worst investors, the worst ST-board. In short: it´s the worst! Weak-hands: not investment advice at all, but SELL NOW! I need more shares... thanks! Very bearish, very very

0 · Reply

djsir Feb. 3 at 6:06 PM

$TGTX funny how there are suddenly a bunch of MW haters out of the blue. All claiming to hold giant positions since the beginning but none of us have ever seen their names

3 · Reply

WolfOfBaySt2025 Feb. 3 at 6:04 PM

$TGTX Bears make money , Bulls make money . Pigs get slaughtered . I’m guessing it might take a while but a lot of you are gonna learn Mike is a pig (at the trough) eating that compensation UP! As you lose to inflation .

0 · Reply

ern1in Feb. 3 at 6:01 PM

$TGTX just saw a k commercial on netflix .... 🤮🤮🤮🤮🤮🤮

0 · Reply

Market Cap	4.67B
Revenue (ttm)	329.00M
Net Income (ttm)	23.38M
EPS (ttm)	N/A
PE Ratio	10.79
Forward PE	16.62
Profit Margin	7.11%
Debt to Equity Ratio	0.40

Volume	1,531,000
Avg Vol	1,934,798
Day's Range	N/A - N/A
Shares Out	158.76M
Stochastic %K	29%
Beta	1.86
Analysts	Strong Sell
Price Target	$44.86